These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38400590)

  • 21. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unraveling DEHP influence on hemoglobin S polymerization in sickle cell disease: Ex vivo, in vitro and in silico analysis.
    Camacho RA; Machado AV; de Oliveira Mendonça F; Teixeira-Alves LR; Guimarães-Nobre CC; Mendonça-Reis E; da Silva PF; Cardim-Pires TR; Miranda-Alves L; Berto-Junior C
    Toxicol In Vitro; 2024 Jun; 98():105832. PubMed ID: 38653437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease.
    Schroeder P; Fulzele K; Forsyth S; Ribadeneira MD; Guichard S; Wilker E; Marshall CG; Drake A; Fessler R; Konstantinidis DG; Seu KG; Kalfa TA
    J Pharmacol Exp Ther; 2022 Mar; 380(3):210-219. PubMed ID: 35031585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease.
    Maier-Redelsperger M; Noguchi CT; de Montalembert M; Rodgers GP; Schechter AN; Gourbil A; Blanchard D; Jais JP; Ducrocq R; Peltier JY
    Blood; 1994 Nov; 84(9):3182-8. PubMed ID: 7524767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MetAP2 inhibition modifies hemoglobin S to delay polymerization and improves blood flow in sickle cell disease.
    Demers M; Sturtevant S; Guertin KR; Gupta D; Desai K; Vieira BF; Li W; Hicks A; Ismail A; Gonçalves BP; Di Caprio G; Schonbrun E; Hansen S; Musayev FN; Safo MK; Wood DK; Higgins JM; Light DR
    Blood Adv; 2021 Mar; 5(5):1388-1402. PubMed ID: 33661300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Free heme and the polymerization of sickle cell hemoglobin.
    Uzunova VV; Pan W; Galkin O; Vekilov PG
    Biophys J; 2010 Sep; 99(6):1976-85. PubMed ID: 20858444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Noomuna P; Risinger M; Zhou S; Seu K; Man Y; An R; Sheik DA; Wan J; Little JA; Gurkan UA; Turrini FM; Kalfa T; Low PS
    Br J Haematol; 2020 Aug; 190(4):599-609. PubMed ID: 32346864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of erythrocyte cation and water content in sickle cell anemia.
    Brugnara C; Bunn HF; Tosteson DC
    Science; 1986 Apr; 232(4748):388-90. PubMed ID: 3961486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis, and Evaluation of Allosteric Effectors for Hemoglobin.
    Enakaya NA; Jefferson A; Chew-Martinez D; Matthews JS
    Acc Chem Res; 2023 Jun; 56(11):1279-1286. PubMed ID: 36946781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sickle Cell Disease and Thromboembolism: New Insights on the Pathophysiology, Diagnosis, and Treatment.
    Dobie G
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interaction of coexistent alpha-thalassemia and sickle cell anemia: a model for the clinical and cellular results of diminished polymerization?
    Embury SH
    Ann N Y Acad Sci; 1985; 445():37-44. PubMed ID: 3893275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron deficiency and sickle cell anemia.
    Rao KR; Patel AR; Honig GR; Vida LN; McGinnis PR
    Arch Intern Med; 1983 May; 143(5):1030-2. PubMed ID: 6679216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model.
    Quezado ZMN; Kamimura S; Smith M; Wang X; Heaven MR; Jana S; Vogel S; Zerfas P; Combs CA; Almeida LEF; Li Q; Quezado M; Horkayne-Szakaly I; Kosinski PA; Yu S; Kapadnis U; Kung C; Dang L; Wakim P; Eaton WA; Alayash AI; Thein SL
    Blood Cells Mol Dis; 2022 Jul; 95():102660. PubMed ID: 35366607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyruvate kinase activators: targeting red cell metabolism in sickle cell disease.
    Xu JZ; Vercellotti GM
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):107-113. PubMed ID: 38066891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.
    Kassa T; Strader MB; Nakagawa A; Zapol WM; Alayash AI
    Metallomics; 2017 Sep; 9(9):1260-1270. PubMed ID: 28770911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voxelotor for the treatment of sickle cell disease in pediatric patients.
    Brown C; Tonda M; Abboud MR
    Expert Rev Hematol; 2022 Jun; 15(6):485-492. PubMed ID: 35671094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ineffective erythropoiesis in sickle cell disease: new insights and future implications.
    El Nemer W; Godard A; El Hoss S
    Curr Opin Hematol; 2021 May; 28(3):171-176. PubMed ID: 33631786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel permeability characteristics of red blood cells from sickle cell patients heterozygous for HbS and HbC (HbSC genotype).
    Dalibalta S; Ellory JC; Browning JA; Wilkins RJ; Rees DC; Gibson JS
    Blood Cells Mol Dis; 2010 Jun; 45(1):46-52. PubMed ID: 20227897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of erythrocytes containing fetal hemoglobin (F cells) in children with sickle cell disease.
    Marcus SJ; Kinney TR; Schultz WH; O'Branski EE; Ware RE
    Am J Hematol; 1997 Jan; 54(1):40-6. PubMed ID: 8980259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.